Recently Elan Corporation, plc (ADR) (NYSE:ELN)'s shareholders voted against management's proposal to invest $1 billion in Theravance Inc (NASDAQ:THRX), a deal which a fellow Fool calculates to be ill...... (read more)

Elan Corporation, plc (ADR) (NYSE:ELN) has been in the news over the past few months because of a hotly contested battle with Royalty Pharma.  The battle began on Feb. 25, 2013, when Royalty offered...... (read more)

The S&P 500 fell nearly 10% in June 2008, and investors began to brace for an eventual market crash later in the year. That was also a time when companies sealed the hatches and girded for tough...... (read more)

After a year-long dream run, Biogen Idec Inc. (NASDAQ:BIIB) lost 5.25% in the week ended Friday, June 7. The drop would have been greater had the stock not recovered in the last two days of the week....... (read more)

Biotechnology's a volatile sector that can intimidate many investors, but it's also a landscape of stocks that can reward portfolios with giant gains. The Nasdaq Biotechnology Index has held its own this...... (read more)

It's been a tough week for equities. Markets stumbled for a third straight day on Wednesday, as investors await with caution and anxiety next week's Federal Open Market Committee hearing. The central...... (read more)

With one product already on the market, one recently approved and four more in various stages of clinical development, Biogen Idec Inc. (NASDAQ:BIIB) has a very strong presence in the multiple sclerosis...... (read more)

To the untrained eye, there are many facts and figures for Biogen Idec Inc. (NASDAQ:BIIB) investors to track, but it's useful to be aware of a company's short sellers. A couple pieces of data we can use...... (read more)

If you somehow glossed over the title of this article, then skipped this paragraph and simply read about the following three stocks without any context, you might think that today was an absolutely miserable...... (read more)